"Verapamil" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A calcium channel blocker that is a class IV anti-arrhythmia agent.
| Descriptor ID |
D014700
|
| MeSH Number(s) |
D02.092.471.683.953
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Verapamil".
Below are MeSH descriptors whose meaning is more specific than "Verapamil".
This graph shows the total number of publications written about "Verapamil" by people in this website by year, and whether "Verapamil" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 1 | 3 |
| 2004 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Verapamil" by people in Profiles.
-
A Primer on the History of Intralesional Verapamil Injection for Peyronie's Disease. Urology. 2023 03; 173:5-7.
-
2013-2014 updates in Peyronie's disease management. Curr Urol Rep. 2014 Dec; 15(12):459.
-
Is intralesional verapamil effective therapy for Peyronie's disease? J Urol. 2012 Sep; 188(3):704-6.
-
Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease. J Sex Med. 2012 Jan; 9(1):288-95.
-
Current approach to the man with acute phase Peyronie's disease--case presentation and discussion. J Sex Med. 2011 Jun; 8(6):1556-8; quiz 1559.
-
Overlapping features of eclampsia and postpartum angiopathy. Neurocrit Care. 2009; 11(2):199-209.
-
Is there a place for conservative treatment in Peyronie's disease? J Sex Med. 2009 Apr; 6(4):903-909.
-
Evidence based or mechanism based therapeutics. Am J Ther. 2009 Jan-Feb; 16(1):1.
-
Comment on 'Topical verapamil HCL, topical trifluoroperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study'. J Sex Med. 2007 Jul; 4(4 Pt 1):1081-2.
-
Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial. J Urol. 2007 Mar; 177(3):972-5.